| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |